510(k) Report

PMA · Approved

Approved

Neurocontrol Freehand System (R)

P950035PMAApproved Aug 15, 1997654-day reviewClass III21 CFR 882.5860

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biocontrol Technology, Inc. · GZC Stimulator, Neuromuscular, Implanted

Approved on Aug 15, 1997 through premarket approval, which rests on the device’s own clinical evidence after a 654-day review.

Decided
Aug 15, 1997
Review
654 days
Class
Class III
Product code
GZC
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P950035 has 10 supplements since 1998: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

1998: 21999: 22000: 42001: 12002: 1
1998high 4 (2000) · low 1 (2001)2002
View FIG. 1 as a table
YearSupplements approved
19982
19992
20004
20011
20021
FIG. 1 — Supplements to P950035, 1998–2002Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GZC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GZC devices

GZC Stimulator, Neuromuscular, Implanted: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GZC

FDA has decided no GZC device since 2007.

Median 510(k) review, days · GZC

Too few GZC 510(k)s in any year since 2007 to give a median.

Recalls per year · GZC

No recall names GZC since 2007.

Adverse event reports per year · GZC

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2025

MAUDE reports naming product code GZC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—01
20230—00
20240—00
20250—00
20260—0—
Cite this page

510(k) Report. “P950035: Neurocontrol Freehand System (R).” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P950035

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026